Disruption of the ERLIN-TM6SF2-APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease.

Disruption of the ERLIN-TM6SF2-APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease.

Non-alcoholic fatty liver disease (NAFLD) is a metabolic disorder characterized by excess lipid accumulation in the liver without significant consumption of alcohol. The transmembrane 6 superfamily member 2 (TM6SF2) E167K missense variant strongly associates with NAFLD in humans. The E167K mutation...

Full description

Bibliographic Details
Main Authors:	Bo-Tao Li, Ming Sun, Yun-Feng Li, Ju-Qiong Wang, Zi-Mu Zhou, Bao-Liang Song, Jie Luo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-08-01
Series:	PLoS Genetics
Online Access:	https://doi.org/10.1371/journal.pgen.1008955

Similar Items

Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains
by: Emanuel Voyiaziakis, et al.
Published: (1999-11-01)

Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes
by: K G Parhofer, et al.
Published: (1996-04-01)

Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.
by: Lakshmi Mundkur, et al.
Published: (2013-01-01)

Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB
by: Krainer, Adrian R., et al.
Published: (2011)

The murine macrophage apoB-48 receptor gene (Apob-48r)homology to the human receptor1
by: Matthew L. Brown, et al.
Published: (2002-08-01)

Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia
by: C. Verseyden, et al.
Published: (2002-02-01)

Microsomal triglyceride transfer protein is essential for hepatic secretion of apoB-100 and apoB-48 but not triglyceride
by: To Yuen Hui, et al.
Published: (2002-05-01)

Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis
by: Caiqin Niu, et al.
Published: (2017-09-01)

Clinical significance of APOB inactivation in hepatocellular carcinoma
by: Gena Lee, et al.
Published: (2018-11-01)

Surface study of apoB1694–1880, a sequence that can anchor apoB to lipoproteins and make it nonexchangeable
by: Libo Wang, et al.
Published: (2009-07-01)

ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice
by: Myron E. Hinsdale, et al.
Published: (2002-09-01)

Gene-gene interaction between apoB and apoE in determining plasma levels and heterogeneity of apoB-containing lipoproteins
by: Andersson, C, et al.
Published: (1998)

APOB is a potential prognostic biomarker in hepatocellular carcinoma
by: Zhifeng Lin, et al.
Published: (2024-02-01)

A fish oil diet produces different degrees of suppression of apoB and triglyceride secretion in human apoB transgenic mouse strains
by: Carol Ko, et al.
Published: (2003-10-01)

Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice
by: Nancy R. Webb, et al.
Published: (2002-09-01)

SUBFRACTIONS OF ATHEROGENIC APOB-LIPOPROTEIDES IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
by: E. A. Utkina, et al.
Published: (2017-08-01)

Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen
by: Jean Michel Petit, et al.
Published: (2003-09-01)

ApoB-54.8, a truncated apolipoprotein found primarily in VLDL, is associated with a nonsense mutation in the apoB gene and hypobetalipoproteinemia.
by: RD Wagner, et al.
Published: (1991-06-01)

Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia
by: J. Kovar, et al.
Published: (2002-07-01)

Overexpression ofapoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted micethan in apoB-100-only mice
by: Karin Conde-Knape, et al.
Published: (2004-12-01)

ApoB48 as an Efficient Regulator of Intestinal Lipid Transport
by: Chunmin C. Lo, et al.
Published: (2020-07-01)

Quantification of apo[a] and apoB in human atherosclerotic lesions.
by: JM Pepin, et al.
Published: (1991-02-01)

Characterization of apoB, E receptor function in the luteinized ovary
by: S Azhar, et al.
Published: (1988-07-01)

A Comparison of Lipids and apoB in Asian Indians and Americans
by: Kavita Singh, et al.
Published: (2021-01-01)

Parent-of-Origin Effects of the APOB Gene on Adiposity in Young Adults.
by: Hagit Hochner, et al.
Published: (2015-10-01)

Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data.
by: R P Eaton, et al.
Published: (1983-10-01)

Association between polymorphisms in the APOB gene and hyperlipidemia in the Chinese Yugur population
by: Q-L. Gu, et al.
Published: (2017-09-01)

ApoB100 and Atherosclerosis: What’s New in the 21st Century?
by: Dimitris Kounatidis, et al.
Published: (2024-02-01)

The Study Of Rs693 And Rs515135 In APOB In People With Familial Hypercholestrolemia
by: Fatemeh Karami, et al.
Published: (2018-12-01)

Dissociation of LPL and LDL: effects of lipoproteins and anti-apoB antibodies.
by: S Y Choi, et al.
Published: (1997-01-01)

The APOB gene polymorphism in the pathogenesis of gallstone disease in pre- and postmenopausal women
by: Karolina Rudzińska, et al.
Published: (2015-02-01)

Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a)
by: Yan-Ting Wang, et al.
Published: (2009-05-01)

Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice
by: Yuko Kako, et al.
Published: (2002-06-01)

Human apoB contributes to increased serum total apo(a) level in <it>LPA </it>transgenic mice
by: Teivainen Päivi A, et al.
Published: (2004-05-01)

Separation of swine plasma LDL from Lpb2/3 heterozygotes into two apoB allelic haplotypes, Lpb2 and Lpb3, with apoB epitope specific antibodies.
by: J Rapacz, Jr, et al.
Published: (1989-02-01)

Does inclusion of apoB measurements cluster with, or augment the phenotype of the metabolic syndrome?
by: Dennis, A, et al.
Published: (2006)

Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice
by: Moon Kyung Choe, et al.
Published: (2021-04-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

Identification of apoB‐100 Peptide‐Specific CD8+ T Cells in Atherosclerosis
by: Paul C. Dimayuga, et al.
Published: (2017-07-01)

Immunization using ApoB-100 peptide–linked nanoparticles reduces atherosclerosis
by: Kuang-Yuh Chyu, et al.
Published: (2022-06-01)